BRAF and metastatic colorectal cancer: Safety and efficacy of encorafenib-cetuximab combination in &lt;i&gt;BRAF&lt;/i&gt; &lt;sup&gt;&lt;i&gt;V600E&lt;/i&gt;&lt;/sup&gt; -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.